Pavan Reddy was named director of the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine. He will lead oncology services, research, and strategic growth at Baylor St. Luke’s Medical Center.
Philip Okala was named system president at City of Hope.
Stephen M. Ansell was named enterprise deputy director and senior deputy director, Midwest, of the Mayo Clinic Cancer Center.
Folakemi Odedina was named enterprise deputy director of community outreach and engagement at Mayo Clinic Cancer Center.
Stacy L. Palmer was named vice president of clinical administration and strategy at Winship Cancer Institute of Emory University.
Alex Parikh was named chief of surgical oncology and chair of the Mays Cancer Center Surgical Committee and Cancer Surgery Subservice Line at the Mays Cancer Center at UT Health San Antonio MD Anderson.
Erik Knudsen was named associate director of basic science research at Roswell Park Comprehensive Cancer Center. Knudsen will also continue as chair of Molecular and Cellular Biology.
Researchers at The University of Texas MD Anderson Cancer Center developed an approach to quantify tumor-specific total mRNA levels from patient tumor samples, which contain both cancer and non-cancer cells.
Mount Sinai researchers identified genes that predict a positive response to selinexor, a multiple myeloma therapy which can have serious side effects for some patients.
Researchers from the Dana-Farber Cancer Institute and the Tisch Cancer Institute at Mount Sinai Medical School showed that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care in 2021, although patient recruitment increased in 2021.
